Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Schmidt

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Environmental Health Perspectives|October 17, 2023
Beyond Wind and Flood: Review of Cyclone Research Spotlights Trauma OutcomesCharles Schmidt
Nature Biotechnology|June 9, 2012
Gintuit cell therapy approval signals shift at US regulatorCharles Schmidt
Scientific American|July 16, 2024
Delta DangerCharles Schmidt
Journal of the National Cancer Institute|February 3, 2005
Without more federal support, success of U.S. stem cell research questionedCharles Schmidt
Journal of the National Cancer Institute|May 15, 2008
Lapatinib study supports cancer stem cell hypothesis, encourages industry researchCharles Schmidt
Nature Biotechnology|April 9, 2013
The startup bugsCharles Schmidt
Environmental Science & Technology|November 26, 2009
Salmon as transport vectors for mercuryCharles Schmidt
Nature Biotechnology|June 19, 2024
Editor's pick: Tenpoint TherapeuticsCharles Schmidt
Nature|December 1, 2016
Biology: A degenerative afflictionCharles Schmidt
Nature|October 19, 2018
The fight against non-communicable disease in emerging economiesCharles Schmidt
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Environmental Health Perspectives|October 17, 2023
Beyond Wind and Flood: Review of Cyclone Research Spotlights Trauma OutcomesCharles Schmidt
Nature Biotechnology|June 9, 2012
Gintuit cell therapy approval signals shift at US regulatorCharles Schmidt
Scientific American|July 16, 2024
Delta DangerCharles Schmidt
Journal of the National Cancer Institute|February 3, 2005
Without more federal support, success of U.S. stem cell research questionedCharles Schmidt
Journal of the National Cancer Institute|May 15, 2008
Lapatinib study supports cancer stem cell hypothesis, encourages industry researchCharles Schmidt
Nature Biotechnology|April 9, 2013
The startup bugsCharles Schmidt
Environmental Science & Technology|November 26, 2009
Salmon as transport vectors for mercuryCharles Schmidt
Nature Biotechnology|June 19, 2024
Editor's pick: Tenpoint TherapeuticsCharles Schmidt
Nature|December 1, 2016
Biology: A degenerative afflictionCharles Schmidt
Nature|October 19, 2018
The fight against non-communicable disease in emerging economiesCharles Schmidt
Pageof 9